Affordable Access

Stromal-derived MAOB promotes prostate cancer growth and progression.

Authors
  • Pu, Tianjie
  • Wang, Jing
  • Wei, Jing
  • Zeng, Alan
  • Zhang, Jinglong
  • Chen, Jingrui
  • Yin, Lijuan
  • Li, Jingjing
  • Lin, Tzu-Ping
  • Melamed, Jonathan
  • Corey, Eva
  • Gao, Allen
  • Wu, Boyang
Publication Date
Feb 09, 2024
Source
eScholarship - University of California
Keywords
License
Unknown
External links

Abstract

Prostate cancer (PC) develops in a microenvironment where the stromal cells modulate adjacent tumor growth and progression. Here, we demonstrated elevated levels of monoamine oxidase B (MAOB), a mitochondrial enzyme that degrades biogenic and dietary monoamines, in human PC stroma, which was associated with poor clinical outcomes of PC patients. Knockdown or overexpression of MAOB in human prostate stromal fibroblasts indicated that MAOB promotes cocultured PC cell proliferation, migration, and invasion and co-inoculated prostate tumor growth in mice. Mechanistically, MAOB induces a reactive stroma with activated marker expression, increased extracellular matrix remodeling, and acquisition of a protumorigenic phenotype through enhanced production of reactive oxygen species. Moreover, MAOB transcriptionally activates CXCL12 through Twist1 synergizing with TGFβ1-dependent Smads in prostate stroma, which stimulates tumor-expressed CXCR4-Src/JNK signaling in a paracrine manner. Pharmacological inhibition of stromal MAOB restricted PC xenograft growth in mice. Collectively, these findings characterize the contribution of MAOB to PC and suggest MAOB as a potential stroma-based therapeutic target.

Report this publication

Statistics

Seen <100 times